Market Research Industry Reports

Calithera Biosciences Inc (CALA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The companys product pipeline includes CB-839, a glutaminase inhibitor in tumor metabolism to treat solid tumors; NCB001158, a small molecule arginase inhibitor based on tumor immunology technology that activates the bodys own immune system to attack and kill cancer cells for the treatment of hematology and oncology diseases; CB-280, a arginase inhibitor used for treating Cystic Fibrosis; CB-708, a CD73 inhibitor against immuno-oncology condidtions. The company works in collaboration with bio-pharmaceutical companies such as Incyte Corp, Bristol-Myers Squibb (BMS), and Mars Symbiosciences Inc. Calithera is headquartered in South San Francisco, California, the US.

Calithera Biosciences Inc (CALA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Calithera Biosciences Raises USD14.5 Million in Venture Financing 10
Calithera Biosciences Raises USD16 Million in Venture Financing 11
Calithera Biosciences Raises US$35 Million In Series D Financing 12
Calithera Biosciences Raises US$2 Million In Series C Financing 13
Calithera Biosciences Raises Additional US$4 Million In Series B Financing 14
Partnerships 15
Bristol-Myers Squibb and Calithera Biosciences Expand Agreement 15
ProTrials Research Enters into Agreement with Calithera Biosciences 16
Licensing Agreements 17
Incyte Enters into Licensing Agreement with Calithera Biosciences 17
Calithera Biosciences Enters into Licensing Agreement with Mars Symbioscience 19
Equity Offering 20
Calithera Biosciences to Raise up to USD50 Million in Public Offering of Shares 20
Calithera Biosciences Raises USD38 Million in Public Offering of Shares 21
Calithera Biosciences Raises USD80.5 Million in Public Offering of Shares 22
Calithera Biosciences Raises USD8 Million in Private Placement of Shares 24
Calithera Biosciences Raises USD80 Million in IPO 26
Calithera Biosciences Inc - Key Competitors 28
Calithera Biosciences Inc - Key Employees 29
Calithera Biosciences Inc - Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Financial Announcements 31
Aug 07, 2018: Calithera Biosciences reports second quarter 2018 financial results and recent highlights 31
May 10, 2018: Calithera Biosciences Reports First Quarter 2018 Financial Results and Recent Highlights 33
Mar 08, 2018: Calithera Biosciences ReportsFourth Quarter 2017 Financial Results and Recent Highlights 35
Nov 02, 2017: Calithera Biosciences Reports Third Quarter 2017 Financial Results and Recent Highlights 37
Aug 08, 2017: Calithera Biosciences Reports Second Quarter 2017 Financial Results and Recent Highlights 38
May 09, 2017: Calithera Biosciences Reports First Quarter 2017 Financial Results and Recent Highlights 39
Mar 16, 2017: Calithera Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Highlights 41
Corporate Communications 43
Oct 03, 2017: Calithera Biosciences Announces Appointment of Sumita Ray as General Counsel 43
Sep 21, 2017: Calithera Biosciences Appoints Blake Wise to Board of Directors 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List Of Tables


Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calithera Biosciences Raises USD14.5 Million in Venture Financing 10
Calithera Biosciences Raises USD16 Million in Venture Financing 11
Calithera Biosciences Raises US$35 Million In Series D Financing 12
Calithera Biosciences Raises US$2 Million In Series C Financing 13
Calithera Biosciences Raises Additional US$4 Million In Series B Financing 14
Bristol-Myers Squibb and Calithera Biosciences Expand Agreement 15
ProTrials Research Enters into Agreement with Calithera Biosciences 16
Incyte Enters into Licensing Agreement with Calithera Biosciences 17
Calithera Biosciences Enters into Licensing Agreement with Mars Symbioscience 19
Calithera Biosciences to Raise up to USD50 Million in Public Offering of Shares 20
Calithera Biosciences Raises USD38 Million in Public Offering of Shares 21
Calithera Biosciences Raises USD80.5 Million in Public Offering of Shares 22
Calithera Biosciences Raises USD8 Million in Private Placement of Shares 24
Calithera Biosciences Raises USD80 Million in IPO 26
Calithera Biosciences Inc, Key Competitors 28
Calithera Biosciences Inc, Key Employees 29

List Of Figures


Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Calithera Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Calithera Biosciences Inc (CALA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

USD 250View Report

Calithera Biosciences Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Calithera Biosciences Inc Company Profile is a detailed strategic and analytical report on Calithera Biosciences Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Antiva Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Antiva Biosciences Inc (Antiva) formerly Hera Therapeutics Inc, is a clinical stage bio-pharmaceutical company focused on the development of novel medicines for the treatment of diseases caused by human papillomavirus

USD 250View Report

Evelo Biosciences Inc (EVLO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Evelo Biosciences Inc (Evelo Biosciences), formerly Evelo Therapeutics Inc is a clinical stage biotechnology company. It focuses on the development of novel medicines designed to act on immune cells in

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2018
No. of Pages :45
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube